<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.beaconcancer.org/index.php?action=history&amp;feed=atom&amp;title=BRAF</id>
	<title>BRAF - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.beaconcancer.org/index.php?action=history&amp;feed=atom&amp;title=BRAF"/>
	<link rel="alternate" type="text/html" href="https://wiki.beaconcancer.org/index.php?title=BRAF&amp;action=history"/>
	<updated>2026-10-17T08:43:28Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.39.5</generator>
	<entry>
		<id>https://wiki.beaconcancer.org/index.php?title=BRAF&amp;diff=22006&amp;oldid=prev</id>
		<title>Victor at 14:23, 27 August 2024</title>
		<link rel="alternate" type="text/html" href="https://wiki.beaconcancer.org/index.php?title=BRAF&amp;diff=22006&amp;oldid=prev"/>
		<updated>2024-08-27T14:23:14Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 14:23, 27 August 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;BRAF is a gene that encodes a protein called B-Raf, which is part of the MAPK/ERK signaling pathway involved in regulating cell growth and division. Mutations in the BRAF gene, particularly the V600E mutation, are commonly found in various cancers, including melanoma, colorectal, and thyroid cancers. These mutations lead to the continuous activation of the B-Raf protein, driving uncontrolled cell proliferation and &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumor &lt;/del&gt;growth. Detecting BRAF mutations in cancer patients is critical for guiding targeted therapy decisions, as specific inhibitors can effectively block the aberrant B-Raf activity. Understanding BRAF mutations allows for personalized treatment approaches, improving the effectiveness of therapies and offering better outcomes for patients with BRAF-mutant cancers.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;BRAF is a gene that encodes a protein called B-Raf, which is part of the MAPK/ERK signaling pathway involved in regulating cell growth and division. Mutations in the BRAF gene, particularly the V600E mutation, are commonly found in various cancers, including melanoma, colorectal, and thyroid cancers. These mutations lead to the continuous activation of the B-Raf protein, driving uncontrolled cell proliferation and &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumour &lt;/ins&gt;growth. Detecting BRAF mutations in cancer patients is critical for guiding targeted therapy decisions, as specific inhibitors can effectively block the aberrant B-Raf activity. Understanding BRAF mutations allows for personalized treatment approaches, improving the effectiveness of therapies and offering better outcomes for patients with BRAF-mutant cancers.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Victor</name></author>
	</entry>
	<entry>
		<id>https://wiki.beaconcancer.org/index.php?title=BRAF&amp;diff=18045&amp;oldid=prev</id>
		<title>Victor: Created page with &quot;BRAF is a gene that encodes a protein called B-Raf, which is part of the MAPK/ERK signaling pathway involved in regulating cell growth and division. Mutations in the BRAF gene, particularly the V600E mutation, are commonly found in various cancers, including melanoma, colorectal, and thyroid cancers. These mutations lead to the continuous activation of the B-Raf protein, driving uncontrolled cell proliferation and tumor growth. Detecting BRAF mutations in cancer patients...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wiki.beaconcancer.org/index.php?title=BRAF&amp;diff=18045&amp;oldid=prev"/>
		<updated>2024-05-21T18:02:59Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;BRAF is a gene that encodes a protein called B-Raf, which is part of the MAPK/ERK signaling pathway involved in regulating cell growth and division. Mutations in the BRAF gene, particularly the V600E mutation, are commonly found in various cancers, including melanoma, colorectal, and thyroid cancers. These mutations lead to the continuous activation of the B-Raf protein, driving uncontrolled cell proliferation and tumor growth. Detecting BRAF mutations in cancer patients...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;BRAF is a gene that encodes a protein called B-Raf, which is part of the MAPK/ERK signaling pathway involved in regulating cell growth and division. Mutations in the BRAF gene, particularly the V600E mutation, are commonly found in various cancers, including melanoma, colorectal, and thyroid cancers. These mutations lead to the continuous activation of the B-Raf protein, driving uncontrolled cell proliferation and tumor growth. Detecting BRAF mutations in cancer patients is critical for guiding targeted therapy decisions, as specific inhibitors can effectively block the aberrant B-Raf activity. Understanding BRAF mutations allows for personalized treatment approaches, improving the effectiveness of therapies and offering better outcomes for patients with BRAF-mutant cancers.&lt;/div&gt;</summary>
		<author><name>Victor</name></author>
	</entry>
</feed>